|
Market Closed -
Nasdaq
16:00:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 7.810 USD | +2.76% |
|
-8.55% | +86.84% |
| 09-21 | Precigen Receives Fda Platform Technology Designation for Adenoverse Platform | CI |
| 09-21 | Precigen's AdenoVerse Receives FDA Platform Technology Designation | MT |
| Market Cap | 2.8B 2.5B 2.32B 2.11B 3.99B 271B 4.01B 27.96B 10.96B 138B 10.5B 10.27B 443B | P/E 2026 * |
35.1x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8B 2.5B 2.32B 2.11B 3.99B 271B 4.01B 27.96B 10.96B 138B 10.5B 10.27B 443B | EV / Sales 2026 * |
11.7x | EV / Sales 2027 * | 6.3x |
| Free-Float |
87.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PGEN | Delayed | |
CBOE
| PGEN | Real-time | |
|
Boerse Muenchen
| I5X | Real-time | |
|
Tradegate
| I5X | Real-time | |
|
Deutsche Boerse AG
| I5X | Delayed | |
|
Börse Stuttgart
| I5X | Delayed |
Last Transcript: Precigen, Inc.
| 1 day | +2.76% | ||
| 1 week | -8.55% | ||
| Current month | -8.76% | ||
| 1 month | +14.85% | ||
| 3 months | +41.23% | ||
| 6 months | +82.90% | ||
| Current year | +86.84% |
| 1 week | 7.35 |  | 8.6 |
| 1 month | 6.76 | | 8.98 |
| Current year | 3.04 | | 8.98 |
| 1 year | 3.04 | | 8.98 |
| 3 years | 0.65 | | 8.98 |
| 5 years | 0.65 | | 8.98 |
| 10 years | 0.65 | | 32.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 64 | 2019-12-31 |
Harry Thomasian
DFI | Director of Finance/CFO | 64 | 2021-09-30 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Randal Kirk
CHM | Chairman | 72 | 2008-01-31 |
Cesar Alvarez
BRD | Director/Board Member | 78 | 2008-01-31 |
Jeffrey Kindler
BRD | Director/Board Member | 70 | 2011-11-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/23/26 | Exercice | Chief Financial Officer | 107,330 | 0.0360% | ||
| 8/26/26 | Sell | Director | -185,000 | 0.0620% | ||
| 8/25/26 | Exercice | Executive/Senior Manager | 237,498 | 0.0796% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.76% | -8.55% | +144.83% | +537.55% | 2.8B | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,051B | |
| +1.93% | +2.11% | +36.82% | +64.90% | 630B | |
| +1.49% | +5.19% | +19.84% | +85.41% | 489B | |
| +2.26% | +0.90% | +66.40% | +39.33% | 359B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 344B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 272B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 246B | |
| +1.82% | +2.94% | +40.43% | +52.78% | 224B | |
| +2.77% | +4.44% | +29.49% | +101.40% | 187B | |
| Average | +1.62% | +1.42% | +40.20% | +107.59% | 380.65B | |
| Weighted average by Cap. | +1.20% | +2.43% | +31.65% | +70.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 239M 213M 198M 180M 341M 23.11B 342M 2.39B 936M 11.78B 897M 877M 37.81B | 444M 396M 368M 335M 633M 42.93B 636M 4.43B 1.74B 21.88B 1.67B 1.63B 70.23B |
| Net income | 86.06M 76.86M 71.5M 65.04M 123M 8.33B 123M 861M 337M 4.25B 323M 316M 13.63B | 246M 219M 204M 186M 350M 23.76B 352M 2.45B 962M 12.11B 922M 902M 38.87B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | US$7.810 | +2.76% | 3,384,174 |
| 26-10-08 | US$7.600 | +0.80% | 3,829,582 |
| 26-10-07 | US$7.540 | -0.13% | 4,152,552 |
| 26-10-06 | US$7.550 | -2.45% | 5,140,065 |
| 26-10-05 | US$7.740 | -9.37% | 10,254,123 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PGEN Stock
Select your edition
All financial news and data tailored to specific country editions
